AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (1.2 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Targeting BMI1 mitigates chemoresistance in ovarian cancer

Anindya Deya, Shailendra Kumar Dhar Dwivedia, Lin Wangb, Md Nazir Hossenc,d, Fiifi Neizer-Ashune, Magdalena Bieniaszb, Priyabrata Mukherjeec,f, John D. Bairdg, Marla Weetallg, Resham Bhattacharyaa,e,f( )
Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
Department of Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA
Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, California Northstate University, Elk Grove, CA 95757, USA
Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, OK 73104, USA
PTC Therapeutics, Inc, South Plainfield, NJ 07080, USA

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

1

Kim S, Han Y, Kim SI, Kim HS, Kim SJ, Song YS. Tumor evolution and chemoresistance in ovarian cancer. NPJ Precis Oncol. 2018;2:20.
Crossref Google Scholar
2

Wang E, Bhattacharyya S, Szabolcs A, et al. Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer. PLoS One. 2011;6(3):e17918.
Crossref Google Scholar
3

Banerjee Mustafi S, Chakraborty PK, Naz S, et al. MDR1 mediated chemoresistance: BMI1 and TIP60 in action. Biochim Biophys Acta. 2016;1859(8):983-993.
Crossref Google Scholar
4

Bhattacharya R, Nicoloso M, Arvizo R, et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 2009;69(23):9090-9095.
Crossref Google Scholar
5

Dey A, Xiong X, Crim A, et al. Evaluating the mechanism and therapeutic potential of PTC-028, a novel inhibitor of BMI-1 function in ovarian cancer. Mol Cancer Therapeut. 2018;17(1):39-49.
Crossref Google Scholar
Genes & Diseases
Volume 9 Issue 6,
November 2022
Pages 1415-1418
DOI: 10.1016/j.gendis.2022.02.006
Cite this article:
Dey A, Dhar Dwivedi SK, Wang L, et al. Targeting BMI1 mitigates chemoresistance in ovarian cancer. Genes & Diseases, 2022, 9(6): 1415-1418. https://doi.org/10.1016/j.gendis.2022.02.006

311

Views

6

Downloads

1

Crossref

1

Web of Science

1

Scopus

0

CSCD

Altmetrics
Received: 22 December 2021
Published: 18 March 2022
© 2022, Chongqing Medical University.

This is an open access article under theCC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return